Tags

Type your tag names separated by a space and hit enter

Rasagiline for motor complications in Parkinson's disease.
Lancet. 2005 Mar 12-18; 365(9463):914-6.Lct

Authors+Show Affiliations

Clarke CE
University of Birmingham and Department of Neurology, City Hospital, Birmingham B18 7QH, UK. c.e.clarke@bham.ac.uk

MeSH

AgedAntiparkinson AgentsCatechol O-Methyltransferase InhibitorsCatecholsDrug Therapy, CombinationDyskinesia, Drug-InducedEnzyme InhibitorsHumansIndansLevodopaMiddle AgedMonoamine Oxidase InhibitorsNitrilesParkinson Disease

Pub Type(s)

Comment
Journal Article

Language

eng

PubMed ID

15766976

Citation

Clarke, Carl E.. "Rasagiline for Motor Complications in Parkinson's Disease." Lancet (London, England), vol. 365, no. 9463, 2005, pp. 914-6.
Clarke CE. Rasagiline for motor complications in Parkinson's disease. Lancet. 2005;365(9463):914-6.
Clarke, C. E. (2005). Rasagiline for motor complications in Parkinson's disease. Lancet (London, England), 365(9463), 914-6.
Clarke CE. Rasagiline for Motor Complications in Parkinson's Disease. Lancet. 2005 Mar 12-18;365(9463):914-6. PubMed PMID: 15766976.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Rasagiline for motor complications in Parkinson's disease. A1 - Clarke,Carl E, PY - 2005/3/16/pubmed PY - 2005/4/9/medline PY - 2005/3/16/entrez SP - 914 EP - 6 JF - Lancet (London, England) JO - Lancet VL - 365 IS - 9463 SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/15766976/Rasagiline_for_motor_complications_in_Parkinson's_disease_ DB - PRIME DP - Unbound Medicine ER -